Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01733004
Title A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merrimack Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Marietta Georgia United States Details
Boston Massachusetts United States Details
Detroit Michigan United States Details
Villejuif France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field